腹泻流行期间,我们采用了SIgA 治疗婴幼儿患者60例,取得较满意疗效,报导如下。临床资料:治疗组60例,男35例,女25例,轻症(腹泻<10次/日)49例,重症(腹泻>10次/日)11例;对照组51例,男34例,女17例,轻症45例,重症6例。二组年龄均为18个月以内。病程在48小时内。大便呈稀水状,常规阴性或见脂肪滴,致病性大肠杆菌培养阴性。治疗:治疗组以SIgA1.5～2mg/公斤/日分3～4次口服,连服4天。对照组以复方新 During the epidemic of diarrhea, we used SIgA treatment of infants and young children in 60 cases, to obtain more satisfactory efficacy, reported as follows. Clinical data: The treatment group of 60 patients, 35 males and 25 females, mild (diarrhea <10 times / day) in 49 cases, severe (diarrhea> 10 times / day) in 11 cases; control group of 51 patients, 34 males, 17 females, 45 cases of mild, severe cases of 6 cases. Both groups are within 18 months of age. Course of disease in 48 hours. Stool was thin water, conventional negative or see fat droplets, pathogenic E. coli culture negative. Treatment: The treatment group to SIgA1.5 ~ 2mg / kg / day 3 to 4 times orally, even for 4 days. Control group to compound new